Evidence map›Paper›PMID 24813258›Full record

ArticleJournal of stroke and cerebrovascular diseases : the official journal of National Stroke Association2014

Quality of life after intra-arterial therapy for acute ischemic stroke.

Melissa M Cortez, Michael J Wilder, Molly McFadden, Jennifer J Majersik

Abstract read
In one paragraph

Article in Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Melissa M CortezDepartment of Neurology, University of Utah, Salt Lake City, UT; Department of Neurology, Mayo Clinic, Scottsdale, AZ. Electronic address: melissa.cortez@hsc.utah.edu.
Michael J WilderDepartment of Neurology, University of Utah, Salt Lake City, UT.
Molly McFaddenDepartment of Neurology, University of Utah, Salt Lake City, UT.
Jennifer J MajersikDepartment of Neurology, University of Utah, Salt Lake City, UT.

Funding

University of Utah Center for Clinical and Translational ScienceUL1TR001067 · NCATS · UNIVERSITY OF UTAH · PI DERE, WILLARD H., HESS, RACHEL · 2013 to 2017
$19.8M
UNIVERSITY OF UTAH CENTER FOR CLINICAL AND TRANSLATIONAL SCIENCE-UL1: BPCAUL1RR025764 · NCRR · UNIVERSITY OF UTAH · PI MCCLAIN, DONALD A. · 2008 to 2011
$19.4M
University of Utah Center for Clinical and Translational Science-UL1UL1TR000105 · NCATS · UNIVERSITY OF UTAH · PI MCCLAIN, DONALD A. · 2012 to 2013
$5.1M
Mentored Scholars Program for Translational Comparative Effectiveness ResearchKM1CA156723 · NCI · UNIVERSITY OF UTAH · PI BYINGTON, CARRIE L. · 2010 to 2010
$2.5M
University of Utah Center for Clinical and Translational Science-TL1TL1RR025762 · NCRR · UNIVERSITY OF UTAH · PI MCCLAIN, DONALD A. · 2008 to 2011
$0k
NCATS NIH HHS 8UL1TR000105NCATS NIH HHS UL1 TR000105NCATS NIH HHS UL1 TR001067NCI NIH HHS 1KM1CA156723NCI NIH HHS KM1 CA156723NCRR NIH HHS 5TL1RR025762-03NCRR NIH HHS TL1 RR025762NCRR NIH HHS UL1 RR025764NCRR NIH HHS UL1RR025764
6 · The paper itself

Abstract

Few data exist about health-related quality of life outcomes after intra-arterial therapy (IAT) for acute ischemic stroke (AIS). We assessed stroke-specific quality of life (SS-QOL) in survivors of stroke after IAT. Consecutive patients undergoing IAT for AIS from 2005 to 2010 were retrospectively identified via an institutional database. SS-QOL (using the SS-QOL score) and disability status (modified Rankin Scale [mRS]) were prospectively assessed via mailed questionnaire. We analyzed quality of life (QOL) scores by domain and summary score, with a summary score of 4 or more defined as a good outcome. Analysis of variance (ANOVA) was used to model the effect of final recanalization status, stroke severity, and mRS on total QOL score. ANOVA and Pearson correlations were used to test the association between stroke severity/mRS and QOL/time since stroke, respectively. Of 99 patients with AIS, 61 responded, yielding 11 interim deaths, 7 incomplete surveys, and 43 complete surveys for analysis. Among responding survivors, overall QOL score was 3.9 (standard deviation 0.7); 77% of these reported good QOL. Scores were higher in recanalized patients in 11 of 12 domains but was significant only for mood. Although mRS was associated with stroke severity, QOL was independent of both. Seventy-seven percent of survivors of AIS who received IAT reported good QOL. Furthermore, these data suggest that SS-QOL is an independent outcome from stroke severity and disability status.

Indexed as

Quality of LifeAgedBrain IschemiaFemaleFibrinolytic AgentsHealth SurveysHumansInjections, Intra-ArterialMaleMiddle AgedRecurrenceRetrospective StudiesStrokeSurveys and QuestionnairesSurvivorsThrombolytic TherapyFibrinolytic AgentsTissue Plasminogen Activatorintra-arterial therapyischemic strokeQuality of life

Identifiers

PMID24813258
PMCPMC4119515

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.